Messenger RNA vaccine technology, once an arcane area of research, became household terminology because of the COVID-19 pandemic, and now scientists are working on an mRNA flu vaccine strategy that, at least in this study, ...
US biotech company Moderna on Tuesday announced positive interim trial results for its vaccine against respiratory syncytial virus (RSV) in adults over the age of 60.
Jan 17, 2023
0
20
A team of researchers at the University of Glasgow has found that when placed together in human tissue, the influenza virus A and the respiratory syncytial virus (RSV) can fuse together, forming a hybrid virus. In their paper ...
As any parent knows, infants are prone to getting respiratory infections. But a new study shows that the infant immune system is stronger than most people think and beats the adult immune system at fighting off new pathogens.
Dec 10, 2021
0
284
A study conducted at the University of Campinas (UNICAMP) in the state of São Paulo, Brazil, shows that compounds produced by gut microbiota (bacteria and other microorganisms) during fermentation of insoluble fiber from ...
Mar 31, 2021
0
89
So you've had COVID and have now recovered. You don't have ongoing symptoms and luckily, you don't seem to have developed long COVID.
Sep 19, 2022
0
18
Vaccines are one of the most effective interventions to prevent the spreading of infectious diseases. They trigger the immune system to produce antibodies that protect the body against infection. However, we still lack efficacious ...
May 14, 2020
2
344
US biotech firm Moderna said Wednesday it had dosed its first participants in a human study of an mRNA vaccine that targets multiple strains of influenza.
Jul 7, 2021
0
777
A team of University of Maryland researchers developed a nasal spray vaccine that delivers the SARS-CoV-2 spike protein into cells of the airway in mice and hamsters, triggering an immune response that significantly reduced ...
Nov 6, 2023
0
72
A study from Ann & Robert H. Lurie Children's Hospital of Chicago discovered that children younger than 5 years with mild to moderate COVID-19 have much higher levels of genetic material for the virus in the nose compared ...
Jul 30, 2020
0
102
